The Durability of Response and Persistence of Resistance to AbbVie's 2 Direct-acting Antiviral Agent (2D) Therapy in Japanese Subjects

Nagoya, Aichi-ken 467-8602, Japan

Matsuyama, Ehime 790-8524, Japan

Fukuoka, Fukuoka 810-8563, Japan

Fukuoka, Fukuoka 814-0180, Japan

Kurume-shi, Fukuoka 830-0011, Japan

Ogaki-shi, Gifu 503-8502, Japan

Maebashi, Gunma 371-8511, Japan

Takasaki-shi, Gunma 370-0829, Japan

Hiroshima, Hiroshima 730-8619, Japan

Hiroshima, Hiroshima 734-8551, Japan

Obihiro-shi, Hokkaido 080-0024, Japan

Sapporo, Hokkaido 060-0033, Japan

Hitachi-shi, Ibaraki 317-0077, Japan

Kanazawa, Ishikawa-ken 920-8641, Japan

Kita-gun, Kagawa-ken 761-0793, Japan

Yokohama, Kanagawa 232-0024, Japan

Yokohama, Kanagawa 236-0004, Japan

Kumamoto, Kumamoto 8628655, Japan

Okayama, Okayama-ken 700-8558, Japan

Osaka, Osaka 534-0021, Japan

Osaka, Osaka 543-8555, Japan

Saga, Saga-ken 849-8501, Japan

Iruma-gun, Saitama 350-0451, Japan

Hamamatsu, Shizuoka 431-3192, Japan

Shimotsuga-gun, Tochigi 321-0293, Japan

Shimotsuke-shi, Tochigi 329-0498, Japan

Bunkyo-ku, Tokyo 113-8431, Japan

Bunkyo-ku, Tokyo 113-8655, Japan

Minato-ku, Tokyo 105-8470, Japan

Minato-ku, Tokyo 108-8642, Japan

Toyama, Toyama 930-8550, Japan

Ube-shi, Yamaguchi 755-8505, Japan

Chuo-shi, Yamanashi 409-3821, Japan

Asakura, 838-0069, Japan

Fukui, 918-8235, Japan

Gifu, 500-8323, Japan

Gifu, 500-8727, Japan

Ikeda, 563-8510, Japan

Inashiki, 300-0332, Japan

Inzai, 270-1613, Japan

Kagoshima, 890-8520, Japan

Kawasaki, 213-8587, Japan

Kawasaki, 214-0021, Japan

Matsuyama, 790-0024, Japan

Okayama, 700-0821, Japan

Osaka, 572-0854, Japan

Saitama, 338-8553, Japan

Suita, 564-0013, Japan

Takamatsu, 760-0065, Japan

Tanabe, 646-8558, Japan

Tokyo, 140-8522, Japan

Tokyo, 180-8610, Japan

Yufu-shi, 879-5503, Japan